Effect of 11 beta-hydroxysteroid dehydrogenase-1 inhibition on hepatic glucose metabolism in the conscious dog.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Physiology. Endocrinology and Metabolism

• Publication date

  2010-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajpendo.00740.2009PMID 20159854PMCID PMC2867371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cortisol Release From Adipose Tissue by 11β-Hydroxysteroid Dehydrogenase Type 1 in Humans

  2009cited by this paper
• Liver Is the Site of Splanchnic Cortisol Production in Obese Nondiabetic Humans

  2009cited by this paper
• Effects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In Vivo

  2009influential reference
• Advances in male contraception.

  2008cited by this paper
• Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome.

  2008cited by this paper
• Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.

  2007cited by this paper
• Extra-adrenal regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning

  2007cited by this paper
• Inhibition of 11β-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis

  2007cited by this paper
• Splanchnic Cortisol Production in Dogs Occurs Primarily in the Liver

  2006influential reference
• Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production.

  2006influential reference
• Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism.

  2005cited by this paper
• Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.

  2005cited by this paper
• Faculty Opinions recommendation of 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.

  2005cited by this paper
• 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.

  2005cited by this paper
• Nonesterified fatty acids and hepatic glucose metabolism in the conscious dog.

  2004cited by this paper
• Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.

  2004cited by this paper
• Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

  2004cited by this paper
• Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway.

  2004cited by this paper
• Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice.

  2004cited by this paper
• 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

  2004cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.

  2004cited by this paper
• Effects of the 11β-Hydroxysteroid Dehydrogenase Inhibitor Carbenoxolone on Insulin Sensitivity in Men with Type 2 Diabetes

  2003cited by this paper
• Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice.

  2003cited by this paper
• Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

  2003cited by this paper
• Enhanced 11beta-hydroxysteroid dehydrogenase type 1 activity in stress adaptation in the guinea pig.

  2003cited by this paper
• Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains.

  2003cited by this paper
• 11β-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes

  2003cited by this paper
• Direct and indirect effects of insulin on glucose uptake and storage by the liver.

  2002cited by this paper
• Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol.

  2002cited by this paper
• Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases.

  2001cited by this paper
• Small increases in insulin inhibit hepatic glucose production solely caused by an effect on glycogen metabolism.

  2001influential reference
• Improved Lipid and Lipoprotein Profile, Hepatic Insulin Sensitivity, and Glucose Tolerance in 11β-Hydroxysteroid Dehydrogenase Type 1 Null Mice*

  2001cited by this paper
• Light and Electron Microscopy Localization of the 11β-Hydroxysteroid Dehydrogenase Type I Enzyme in the Rat.

  2001cited by this paper
• A Transgenic Model of Visceral Obesity and the Metabolic Syndrome

  2001cited by this paper
• Light and electron microscopy localization of the 11beta-hydroxysteroid dehydrogenase type I enzyme in the rat.

  2001cited by this paper
• Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1

  1998cited by this paper
• Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues.

  1998cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.

  1997cited by this paper
• Effects of morning rise in cortisol concentration on regulation of lipolysis in subcutaneous adipose tissue.

  1996cited by this paper
• Cloning and sequencing of the 5′ region of the human glucose‐6‐phosphatase gene: transcriptional regulation by cAMP, insulin and glucocorticoids in H4IIE hepatoma cells

  1996cited by this paper
• Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog.

  1996cited by this paper
• Effects of an Acute Increase in Epinephrine and Cortisol on Carbohydrate Metabolism During Insulin Deficiency

  1995cited by this paper
• Effects of chronic hypercortisolemia on carbohydrate metabolism during insulin deficiency.

  1994cited by this paper
• Pulsatility does not alter the response to a physiological increment in glucagon in the conscious dog.

  1994cited by this paper
• Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.

  1992cited by this paper
• Estimation of the rate of appearance in the non-steady state with a two-compartment model.

  1992cited by this paper
• Glucagon-cortisol interactions on glucose turnover and lactate gluconeogenesis in normal humans.

  1990cited by this paper
• Regulation of the hepatic response to glucagon: role of insulin, growth hormone and cortisol.

  1989cited by this paper
• Gluconeogenesis and related aspects of glycolysis.

  1983cited by this paper
• Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.

  1979cited by this paper
• Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate.

  1978cited by this paper
• Role of cortisol on the glycogenolytic effect of glucagon and on the glycogenic response to insulin in fetal hepatocyte culture.

  1976cited by this paper
• Adrenal corticosteroid involvement in the control of liver glycogen phosphorylase activity.

  1969cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Cortisol Metabolism in Human Obesity: Impaired Cortisone3Cortisol Conversion in Subjects with Central Adiposity*

  year unknowncited by this paper

• Computational prediction of 11β-hydroxysteroid dehydrogenase inhibitors from n-butanol fraction of Blighia welwetschii (Hiern) leaf for the management of type-2 diabetes

  2023cites this paper
• 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

  2023cites this paper
• Inhibition of 11β‐Hydroxysteroid dehydrogenase‐1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled, phase II study

  2022cites this paper
• Glucocorticoid Metabolism and Activation

  2019cites this paper
• 11β Hydroxysteroid dehydrogenase – 1 activity in type 2 diabetes mellitus: a comparative study

  2019cites this paper
• Asparagus racemosus Linn. Potentiates the Hypolipidemic and Hepatoprotective Activity of Fenofibrate in Alloxan-Induced Diabetic Rats

  2016cites this paper
• Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.

  2016cites this paper
• Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes.

  2015cites this paper
• Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta‐hydroxysteroid dehydrogenase 1 and autocrinal regulation

  2014cites this paper
• Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?

  2014cites this paper
• Effects of acute glucocorticoid blockade on metabolic dysfunction in patients with Type 2 diabetes with and without fatty liver

  2014cites this paper
• Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism.

  2014cites this paper
• Population pharmacokinetics of the 11β‐hydroxysteroid dehydrogenase type 1 inhibitor ABT‐384 in healthy volunteers following single and multiple dose regimens

  2014cites this paper
• 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

  2013cites this paper
• Evaluation of liver glycogen catabolism during hypercortisolism induced by the administration of dexamethasone in rats

  2013cites this paper
• Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.

  2013cites this paper
• Effect of Ketoconazole on the Pharmacokinetics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 and Its Two Active Metabolites in Healthy Volunteers: Population Analysis of Data from a Drug-Drug Interaction Study

  2013cites this paper
• Effects of 11β-hydroxysteroid dehydrogenase-1 inhibition on hepatic glycogenolysis and gluconeogenesis.

  2013cites this paper
• Neonatal overfeeding causes higher adrenal catecholamine content and basal secretion and liver dysfunction in adult rats

  2013cites this paper
• 11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.

  2013cites this paper
• Sixty Years after Hench — Corticosteroids and Chronic Inflammatory Disease

  2012cites this paper
• Sixty years after Hench--corticosteroids and chronic inflammatory disease.

  2012cites this paper
• Liver Upregulation of Genes Involved in Cortisol Production and Action Is Associated with Metabolic Syndrome in Morbidly Obese Patients

  2012cites this paper
• 7. Mental Stress

  2012cites this paper
• Is there sufficient evidence to consider the use of 11β‐hydroxysteroid dehydrogenase type 1 inhibition in children?

  2012cites this paper
• [The metabolic syndrome as intrahepatocytic Cushing's syndrome].

  2011cites this paper
• Reduction du risque metabolique associe a l'obesite en modulant l'exposition tissulaire au cortisol.

  2010cites this paper